TPGS1
gene geneOn this page
Also known as GTRGEO22PGs1
Summary
TPGS1 (tubulin polyglutamylase complex subunit 1, HGNC:25058) is a protein-coding gene on chromosome 19p13.3, encoding Tubulin polyglutamylase complex subunit 1 (Q6ZTW0). Subunit of the tubulin polyglutamylase complex (TPGC).
Predicted to enable microtubule binding activity and tubulin-glutamic acid ligase activity. Predicted to be involved in sperm axoneme assembly. Predicted to act upstream of or within several processes, including adult behavior; chemical synaptic transmission; and protein polyglutamylation. Located in centrosome.
Source: NCBI Gene 91978 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 50 total
- MANE Select transcript:
NM_033513
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25058 |
| Approved symbol | TPGS1 |
| Name | tubulin polyglutamylase complex subunit 1 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | GTRGEO22, PGs1 |
| Ensembl gene | ENSG00000141933 |
| Ensembl biotype | protein_coding |
| OMIM | 620709 |
| Entrez | 91978 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 retained_intron
ENST00000359315, ENST00000588278
RefSeq mRNA: 1 — MANE Select: NM_033513
NM_033513
CCDS: CCDS42454
Canonical transcript exons
ENST00000359315 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000951304 | 507497 | 507844 |
| ENSE00001431625 | 518889 | 519654 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 85.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 16.5722 / max 169.2802, expressed in 1805 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 172681 | 16.5722 | 1805 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 85.53 | gold quality |
| mucosa of stomach | UBERON:0001199 | 85.11 | gold quality |
| leukocyte | CL:0000738 | 85.04 | gold quality |
| metanephros cortex | UBERON:0010533 | 84.58 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 84.55 | gold quality |
| ascending aorta | UBERON:0001496 | 84.15 | gold quality |
| thoracic aorta | UBERON:0001515 | 84.12 | gold quality |
| tibial artery | UBERON:0007610 | 83.86 | gold quality |
| popliteal artery | UBERON:0002250 | 83.85 | gold quality |
| apex of heart | UBERON:0002098 | 83.81 | gold quality |
| aorta | UBERON:0000947 | 83.76 | gold quality |
| left coronary artery | UBERON:0001626 | 83.53 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 83.51 | gold quality |
| right adrenal gland | UBERON:0001233 | 83.46 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 83.45 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 83.34 | gold quality |
| left adrenal gland | UBERON:0001234 | 83.30 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 83.27 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 83.24 | gold quality |
| endocervix | UBERON:0000458 | 82.96 | gold quality |
| granulocyte | CL:0000094 | 82.90 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 82.54 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 82.52 | gold quality |
| ectocervix | UBERON:0012249 | 82.51 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.50 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 82.23 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 81.90 | gold quality |
| lower esophagus | UBERON:0013473 | 81.88 | gold quality |
| body of uterus | UBERON:0009853 | 81.86 | gold quality |
| body of stomach | UBERON:0001161 | 81.56 | gold quality |
Single-cell (SCXA)
Detected in 11 experiment(s), a significant marker in 9.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9435 | yes | 1841.15 |
| E-CURD-79 | yes | 1830.37 |
| E-MTAB-8142 | yes | 100.62 |
| E-CURD-88 | yes | 43.04 |
| E-HCAD-1 | yes | 38.17 |
| E-MTAB-6701 | yes | 29.98 |
| E-GEOD-135922 | yes | 25.71 |
| E-HCAD-10 | yes | 8.19 |
| E-ANND-3 | yes | 3.59 |
| E-GEOD-137537 | no | 2558.76 |
| E-HCAD-8 | no | 793.98 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
2 targeting TPGS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
Literature-anchored findings (GeneRIF, showing 1)
- Isolation and functional characterization of the mouse PGs1 ortholog, and comparison to the human protein. (PMID:12972506)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tpgs1 | ENSDARG00000027547 |
| mus_musculus | Tpgs1 | ENSMUSG00000020308 |
| rattus_norvegicus | Tpgs1 | ENSRNOG00000008296 |
Protein
Protein identifiers
Tubulin polyglutamylase complex subunit 1 — Q6ZTW0 (reviewed: Q6ZTW0)
All UniProt accessions (1): Q6ZTW0
UniProt curated annotations — full annotation on UniProt →
Function. Subunit of the tubulin polyglutamylase complex (TPGC). The complex mediates cilia and flagella polyglutamylation which is essential for their biogenesis and motility. May act in the targeting of the tubulin polyglutamylase complex. Required for the development of the spermatid flagellum.
Subunit / interactions. Part of the neuronal tubulin polyglutamylase complex which contains TPGS1, TPGS2, TTLL1, LRRC49 and NICN1. Interacts with PCM1, CSTPP1 and LRRC49.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme. Cilium basal body. Flagellum basal body. Cell projection. Axon. Dendrite. Microtubule organizing center. Centrosome. Centriolar satellite.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6ZTW0-1 | 1 | yes |
| Q6ZTW0-2 | 2 |
RefSeq proteins (1): NP_277048* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR039235 | TPGS1 | Family |
| IPR047502 | DD_TPGS1 | Domain |
| IPR057632 | TPGS1_C | Domain |
Pfam: PF24480
UniProt features (5 total): modified residue 2, chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZTW0-F1 | 81.46 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 34, 266
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin |
MSigDB gene sets: 314 (showing top):
GSE45365_NK_CELL_VS_CD11B_DC_DN, GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, GOBP_BEHAVIOR, GOBP_VESICLE_LOCALIZATION, GOBP_ADULT_BEHAVIOR, GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS, GOBP_MALE_GAMETE_GENERATION, GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS, GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_CELL_CELL_SIGNALING, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS, GOBP_GLYCEROLIPID_METABOLIC_PROCESS, GGAANCGGAANY_UNKNOWN
GO Biological Process (10): chemical synaptic transmission (GO:0007268), sperm axoneme assembly (GO:0007288), adult behavior (GO:0030534), vesicle localization (GO:0051648), microtubule cytoskeleton organization (GO:0000226), spermatogenesis (GO:0007283), protein polyglutamylation (GO:0018095), cell differentiation (GO:0030154), microtubule polymerization (GO:0046785), cilium disassembly (GO:0061523)
GO Molecular Function (3): microtubule binding (GO:0008017), tubulin-glutamic acid ligase activity (GO:0070740), tubulin binding (GO:0015631)
GO Cellular Component (13): centrosome (GO:0005813), microtubule organizing center (GO:0005815), microtubule (GO:0005874), axoneme (GO:0005930), axon (GO:0030424), dendrite (GO:0030425), centriolar satellite (GO:0034451), synapse (GO:0045202), cytoplasm (GO:0005737), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 5 |
| developmental process involved in reproduction | 2 |
| microtubule cytoskeleton | 2 |
| neuron projection | 2 |
| anterograde trans-synaptic signaling | 1 |
| axoneme assembly | 1 |
| sperm flagellum assembly | 1 |
| behavior | 1 |
| organelle localization | 1 |
| cytoskeleton organization | 1 |
| microtubule-based process | 1 |
| male gamete generation | 1 |
| peptidyl-glutamic acid modification | 1 |
| cellular developmental process | 1 |
| microtubule nucleation | 1 |
| microtubule polymerization or depolymerization | 1 |
| protein polymerization | 1 |
| supramolecular fiber organization | 1 |
| cilium organization | 1 |
| organelle disassembly | 1 |
| tubulin binding | 1 |
| protein-glutamic acid ligase activity | 1 |
| cytoskeletal protein binding | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| polymeric cytoskeletal fiber | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| dendritic tree | 1 |
| centrosome | 1 |
| cell junction | 1 |
| intracellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
460 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TPGS1 | LRRC49 | Q8IUZ0 | 732 |
| TPGS1 | REX1BD | Q96EN9 | 625 |
| TPGS1 | TTC13 | Q8NBP0 | 575 |
| TPGS1 | CATIP | Q7Z7H3 | 572 |
| TPGS1 | OR4K15 | Q8NH41 | 564 |
| TPGS1 | TEX55 | Q96M34 | 527 |
| TPGS1 | CIMAP1D | Q3SX64 | 506 |
| TPGS1 | FBXL13 | Q8NEE6 | 505 |
| TPGS1 | AK8 | Q96MA6 | 504 |
| TPGS1 | CCDC177 | Q9NQR7 | 493 |
| TPGS1 | GPRIN1 | Q7Z2K8 | 487 |
| TPGS1 | EFCAB10 | A6NFE3 | 448 |
| TPGS1 | A0A0G2JP48 | A0A0G2JP48 | 446 |
| TPGS1 | R3HDM4 | Q96D70 | 433 |
| TPGS1 | TPGS2 | Q68CL5 | 410 |
IntAct
47 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CEP290 | CCP110 | psi-mi:“MI:2364”(proximity) | 0.890 |
| EIF3F | EIF3CL | psi-mi:“MI:0914”(association) | 0.640 |
| NICN1 | TTLL1 | psi-mi:“MI:0914”(association) | 0.640 |
| TTLL1 | CDC27 | psi-mi:“MI:0914”(association) | 0.640 |
| LRRC49 | EIF3F | psi-mi:“MI:0914”(association) | 0.640 |
| LRRC49 | SNAP29 | psi-mi:“MI:0914”(association) | 0.530 |
| ANO4 | ANO6 | psi-mi:“MI:0914”(association) | 0.530 |
| ANP32E | KPNA6 | psi-mi:“MI:0914”(association) | 0.530 |
| GSK3B | SEC16A | psi-mi:“MI:2364”(proximity) | 0.420 |
| PCM1 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| LRRC49 | PCM1 | psi-mi:“MI:0914”(association) | 0.350 |
| SMG8 | HSP90AA4P | psi-mi:“MI:0914”(association) | 0.350 |
| ROS1 | ODAD3 | psi-mi:“MI:0914”(association) | 0.350 |
| TPGS1 | PPFIA3 | psi-mi:“MI:0914”(association) | 0.350 |
| TPGS1 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.350 |
| CSTPP1 | PEX5 | psi-mi:“MI:0914”(association) | 0.350 |
| TTLL1 | CAMK2B | psi-mi:“MI:0914”(association) | 0.350 |
| CSTPP1 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| NICN1 | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| TTLL1 | RGS12 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP290 | ARPC3 | psi-mi:“MI:2364”(proximity) | 0.270 |
| KIAA0753 | DVL1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP128 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SSX2IP | CCDC85C | psi-mi:“MI:2364”(proximity) | 0.270 |
| PCM1 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| STIL | ERVK3-1 | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (104): TPGS1 (Affinity Capture-MS), TPGS1 (Affinity Capture-MS), TPGS1 (Proximity Label-MS), TPGS1 (Affinity Capture-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS), TPGS1 (Proximity Label-MS)
ESM2 similar proteins: A5PJU7, A8MQ27, F1MLB4, F1MX48, F1SAM7, I3L5V6, O75425, O95382, P36916, Q08DG4, Q0MW30, Q14451, Q2YD98, Q32P44, Q3MIP1, Q3T033, Q3UPE3, Q3UV16, Q505F5, Q5EBM0, Q5U651, Q5ZM20, Q641Q3, Q6MG06, Q6SZW1, Q6ZTW0, Q7T0L4, Q8BGG6, Q8BH83, Q8C0R7, Q8K0Y7, Q8N9W5, Q8R2K4, Q8TE68, Q8VC03, Q96BM1, Q96E14, Q96EF6, Q96EY9, Q99JB7
Diamond homologs: Q6ZTW0, Q99MS8
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| TPGS1 | “form complex” | “Tubulin polyglutamylase complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 64 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Loss of Nlp from mitotic centrosomes | 5 | 18.9× | 8e-04 |
| Loss of proteins required for interphase microtubule organization from the centrosome | 5 | 18.9× | 8e-04 |
| AURKA Activation by TPX2 | 5 | 18.1× | 8e-04 |
| Recruitment of mitotic centrosome proteins and complexes | 5 | 16.2× | 1e-03 |
| Anchoring of the basal body to the plasma membrane | 6 | 16.1× | 7e-04 |
| Regulation of PLK1 Activity at G2/M Transition | 5 | 15.1× | 1e-03 |
| Recruitment of NuMA to mitotic centrosomes | 5 | 13.9× | 2e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| centriole replication | 5 | 65.4× | 6e-06 |
| cilium assembly | 8 | 10.5× | 2e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
50 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 2 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3751 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:78378805:GGAG:G | donor_gain | 1.0000 |
| 17:78378806:G:GT | donor_gain | 1.0000 |
| 17:78378806:GAGGT:G | donor_loss | 1.0000 |
| 17:78378809:GTGA:G | donor_loss | 1.0000 |
| 17:78378810:T:G | donor_loss | 1.0000 |
| 17:78398246:T:TA | acceptor_gain | 1.0000 |
| 17:78398247:GGTA:G | acceptor_loss | 1.0000 |
| 17:78398249:TAGGT:T | acceptor_loss | 1.0000 |
| 17:78398250:A:T | acceptor_loss | 1.0000 |
| 17:78398350:AGGT:A | donor_loss | 1.0000 |
| 17:78398352:G:C | donor_loss | 1.0000 |
| 17:78399341:T:TA | acceptor_gain | 1.0000 |
| 17:78399345:CAGGC:C | acceptor_loss | 1.0000 |
| 17:78399534:GCGG:G | donor_gain | 1.0000 |
| 17:78399536:GG:G | donor_gain | 1.0000 |
| 17:78399537:GG:G | donor_gain | 1.0000 |
| 17:78399538:G:C | donor_loss | 1.0000 |
| 17:78399538:G:GG | donor_gain | 1.0000 |
| 17:78399539:T:G | donor_loss | 1.0000 |
| 17:78400672:TGTAG:T | acceptor_loss | 1.0000 |
| 17:78400673:GTA:G | acceptor_loss | 1.0000 |
| 17:78400674:TA:T | acceptor_loss | 1.0000 |
| 17:78400675:A:AG | acceptor_gain | 1.0000 |
| 17:78400675:A:C | acceptor_loss | 1.0000 |
| 17:78400675:AGT:A | acceptor_gain | 1.0000 |
| 17:78400676:G:GC | acceptor_gain | 1.0000 |
| 17:78400676:GT:G | acceptor_gain | 1.0000 |
| 17:78400676:GTG:G | acceptor_gain | 1.0000 |
| 17:78400676:GTGC:G | acceptor_gain | 1.0000 |
| 17:78400676:GTGCA:G | acceptor_gain | 1.0000 |
AlphaMissense
1839 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:519092:T:C | F181S | 0.998 |
| 19:519371:T:C | F274S | 0.998 |
| 19:507702:T:C | F66L | 0.997 |
| 19:507704:C:A | F66L | 0.997 |
| 19:507704:C:G | F66L | 0.997 |
| 19:518896:T:C | F116L | 0.997 |
| 19:518898:C:A | F116L | 0.997 |
| 19:518898:C:G | F116L | 0.997 |
| 19:518969:G:A | G140E | 0.997 |
| 19:507820:T:A | L105H | 0.996 |
| 19:518897:T:C | F116S | 0.996 |
| 19:518977:T:G | Y143D | 0.996 |
| 19:519395:T:C | F282S | 0.996 |
| 19:507718:T:C | F71S | 0.995 |
| 19:518918:C:A | A123D | 0.995 |
| 19:518968:G:T | G140W | 0.995 |
| 19:518969:G:T | G140V | 0.995 |
| 19:519091:T:C | F181L | 0.995 |
| 19:519093:C:A | F181L | 0.995 |
| 19:519093:C:G | F181L | 0.995 |
| 19:519130:T:C | F194L | 0.995 |
| 19:519132:C:A | F194L | 0.995 |
| 19:519132:C:G | F194L | 0.995 |
| 19:507658:C:A | A51D | 0.994 |
| 19:518920:T:G | Y124D | 0.994 |
| 19:518987:T:C | L146P | 0.994 |
| 19:518990:T:A | L147H | 0.994 |
| 19:519077:T:A | V176E | 0.994 |
| 19:519370:T:C | F274L | 0.994 |
| 19:519372:T:A | F274L | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000152843 (19:514582 A>C), RS1000265907 (19:509353 C>A), RS1000573842 (19:506260 A>C), RS1000762902 (19:509165 G>A), RS1000809319 (19:511682 G>A), RS1001068920 (19:506860 G>A,C), RS1001142567 (19:510851 T>G), RS1001167162 (19:515413 A>G), RS1001193143 (19:510738 T>C), RS1001198199 (19:515093 C>A,T), RS1001336195 (19:506921 T>C,G), RS1001383057 (19:510556 G>A,T), RS1001450528 (19:510905 A>T), RS1002288060 (19:507127 T>A), RS1002424299 (19:506993 T>C)
Disease associations
OMIM: gene MIM:620709 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002396_3 | Mean reticulocyte volume | 1.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010701 | mean reticulocyte volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| fluorene-9-bisphenol | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| bisphenol S | decreases methylation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Arsenic | increases methylation | 1 |
| Cisplatin | increases expression, affects cotreatment | 1 |
| Estradiol | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | decreases expression, increases methylation | 1 |
| Palmitic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.